Moneys Magazine meets Ido Zamberg, CPO & Co-Founder of HeadToToe.
HeadToToe is a cloud-based mHealth platform for management and dissemination of guidance in hospitals. This includes all the clinical and administrative guidance used by medical teams in their daily practice. Today, there is no single source of truth for guidance in hospitals, with content being stored in fragmented and disconnected software. This makes it extremely difficult for medical teams to access their knowledge base, get updated on changes in guidance and collaborate with other teams. The result is significant operational inefficiencies and medical errors. HeadToToe was created by medical doctors to address the daily needs of their teams and is being used in hospitals in the US, Canada and Europe. With HeadToToe, medical teams can access any item in their knowledge base within seconds. The system automatically manages the quality of the content, and notifies stakeholders on changes in clinical guidance. Health professionals have access not only to their department’s guidance – but also to that of their entire hospital. Finally, usage analytics inform decision makers on content usage patterns.
Ido, tell us more about you and your background!
I am a medical doctor, graduated from the University of Geneva, Switzerland. I specialize in General Internal Medicine and in Anesthesiology and practicing in the Geneva University Hospitals. I am as well a Medical Education Fellow at Johns Hopkins University, USA, and a computer scientist, with 10+ years experience as a database expert and mobile development in enterprises such as Mercury, HP & Autodesk and a Startup that was sold to Autodesk in 2013. I am the head of product @HeadToToe.
When was your company born and who is your core team?
We are an early stage startup, born in November 2021. However, the product was launched already in 2019 at the University of Geneva and the Geneva University Hospitals and became an institutional tool in 2020.
We are 3 co-founders, Myself, Galia (https://www.linkedin.com/in/galiars/) is our CEO, she comes from a strong business background and is a GTM expert and Olivier (https://www.linkedin.com/in/olivier-windisch-21b7781a7/), who is a urological surgeon and who leads the clinical research part.
How did you scale your company to the actual size?
We are an early stage but work already with > 10 hospitals in the EU and the USA. We were funded until now by grants from the Private foundation of the Geneva University Hospitals, the University of Geneva, and won the Credit Suisse Award for best teaching in 2020.
Next step?
We are starting our pre-seed round, which will aim to penetrate the US Market, develop our product, build a strong team, and demonstrate our ROI through clinical research.
